Literature DB >> 12414652

Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.

Debdutta Bandyopadhyay1, Nihal A Okan, Elise Bales, Lucia Nascimento, Philip A Cole, Estela E Medrano.   

Abstract

The histone acetyltransferases p300 and cAMP-responsive element-binding protein-binding protein (CBP) are required for the execution of critical biological functions such as proliferation, differentiation, and apoptosis. Both proteins are believed to regulate the activity of a large number of general and cell-specific transcription factors. Here we demonstrate a dramatic decrease in the total cellular levels of p300 and CBP with increasing population doublings of human normal melanocytes. We show that one consequence of p300 depletion is transcriptional down-regulation of the cyclin E gene, caused by deacetylation of histones at its promoter. The cyclin E promoter was activated by p300 and the histone deacetylase inhibitor trichostatin A. Conversely, the cyclin E promoter was repressed by wild-type Retinoblastoma tumor suppressor p105 protein (pRB) and by a dominant negative p300 mutant (DN p300) that lacks histone acetyltransferase activity. We also provide evidence of the alternative recruitment of p300 and histone deacetylase 1 to the cyclin E promoter in proliferating and senescent melanocytes, respectively. The biological significance of these results was established by showing that block of p300 activity by overexpression of DN p300 or by Lys-CoA, a specific chemical inhibitor of p300, resulted in growth inhibition, down-regulation of cyclin E, and activation of the senescence-associated beta-galactosidase marker in human melanocytes and melanoma cells. Together, these results provide evidence for the essential role of p300 in the regulation of proliferation and senescence in cells from melanocytic origin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414652

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  58 in total

1.  Gene expression profiles of giant hairy naevi.

Authors:  M R K Dasu; R E Barrow; H K Hawkins; R L McCauley
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

2.  Identification of age-specific Nrf2 binding to a novel antioxidant response element locus in the Gclc promoter: a compensatory means for the loss of glutathione synthetic capacity in the aging rat liver?

Authors:  Swapna V Shenvi; Eric Smith; Tory M Hagen
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

Review 3.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

4.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

5.  p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

Authors:  Sumit Isharwal; Michael C Miller; Cameron Marlow; Danil V Makarov; Alan W Partin; Robert W Veltri
Journal:  Prostate       Date:  2008-07-01       Impact factor: 4.104

Review 6.  MHC class II regulation by epigenetic agents and microRNAs.

Authors:  Thomas B Tomasi; William J Magner; Jennifer L Wiesen; Julian Z Oshlag; Felicia Cao; Alex N Pontikos; Christopher J Gregorie
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

7.  Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.

Authors:  M Columbaro; C Capanni; E Mattioli; G Novelli; V K Parnaik; S Squarzoni; N M Maraldi; G Lattanzi
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

8.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

9.  Gene clusters, molecular evolution and disease: a speculation.

Authors:  Leah I Elizondo; Paymaan Jafar-Nejad; J Marietta Clewing; Cornelius F Boerkoel
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

10.  14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.

Authors:  Julia Schultz; Saleh M Ibrahim; Julio Vera; Manfred Kunz
Journal:  Mol Cancer       Date:  2009-07-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.